The CEO of Peptilogics boils down leadership in the unpredictable, long-haul life sciences industry to three traits. Leaders must adapt to rapid changes, maintain a steady hand for the decade-plus development cycles, and provide a clear, guiding vision throughout.

Related Insights

For teams that operate in rapid cycles, like a newsroom, the leader's most valuable trait is predictability. This consistency provides a stable foundation, empowering the team to act quickly and autonomously without being destabilized by their manager's shifting priorities, which would slow down operations.

A CEO's primary role differs fundamentally based on company type. In an asset-centric biotech, the CEO must act as a hands-on program manager, micromanaging execution. In a platform company, the CEO must be deeply embedded in the science to predict and leverage the technology's long-term trajectory.

CEO Oliver Karaz defines his role by three decision types: 1) hiring senior leaders he can trust to run their domains, 2) absorbing blame for calculated risks to encourage team innovation, and 3) integrating diverse inputs to set the company’s long-term 'where the puck is going' strategy.

The ability to remain calm and steady through market cycles and intense pressure is a distinct, non-negotiable skill for senior leaders. The Lovesack CEO has seen many otherwise smart and talented people fail because they couldn't manage the psychological strain, making this resilience a key differentiator.

Effective long-term leadership isn't static; it's an 'accordion' that flexes between deep involvement and granting autonomy. This adaptive approach is key for different company seasons, knowing when to lean into details and when to empower the team to make 'foot fault' mistakes and learn.

Successful biotech leadership requires a clear decision-making hierarchy. Dr. Bahija Jallal advocates for a framework where patient welfare is paramount, followed by scientific rigor. Financial success is treated as a byproduct of excelling in the first two areas, not the primary goal.

Recognizing that business leaders—not scientists—often set research priorities, Jonathan Steckbeck intentionally earned an MBA before his PhD. This nontraditional path gave him the commercial acumen to found a company where he could direct both the scientific and business strategy from day one.

Success at the leadership level requires a developed tolerance for pressure and uncertainty—a skill the CEO calls a 'stomach' for it. This resilience is a distinct capability, and its absence can cause even the most intelligent and talented individuals to fail under pressure, making it a crucial trait for high-stakes roles.

While success is celebrated publicly, some of the best leadership happens privately when a CEO makes the tough, candid call to shut down a program or company due to unfavorable data. This "truth-seeking" decision, often against their personal interest, is a hallmark of excellence.

Kenai CEO Nick Manusos attributes his startup success to his varied background at Abbott Labs, moving from manufacturing to sales to BD. This breadth prepared him to handle the multifaceted demands of a startup, where a leader must be a generalist who is comfortable with constant change.